A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Ophthalmic Solutions; Pharmaceutical Solutions; Timolol; Travoprost

Criteria

Inclusion Criteria:

• Adult patients with open-angle glaucoma or ocular hypertension;

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Visual acuity worse than 0.60;

• Other protocol-defined exclusion criteria may apply.